Delivery Order SPE2DE24D0013-SPE2D626F6143
- Not listed
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain office, awarded a firm fixed-price delivery order valued at $8,840 to Cepheid Inc. on July 29, 2025, with an ultimate completion date of August 5, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic testing solutions, specifically reagents and test kits for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). The contract carries no set-aside designation and will be...
- Cepheid Inc., a molecular diagnostic solutions manufacturer based in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $2,040 by the Defense Logistics Agency's Medical Supply Chain division on August 22, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is scheduled for completion by August 29, 2025, and covers molecular diagnostic testing solutions for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). This award carries no set-aside...
- The U.S. Defense Logistics Agency, through its Medical Supply Chain division, awarded Cepheid Inc. a delivery order valued at $22,240 on September 9, 2025, for molecular diagnostic testing solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV). This firm fixed-price delivery order, which has no set-aside designation, is scheduled for completion by September 16, 2025, and will be performed at Cepheid's facility in Sunnyvale, California. Cepheid is a for-profit...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems and reagents, was awarded a delivery order valued at $5,236.00 by the Defense Logistics Agency Medical Supply Chain on October 27, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is for diagnostic testing supplies supporting detection of COVID-19, influenza, and respiratory syncytial virus, with a firm fixed-price structure and ultimate completion date of November 10, 2025. The contract...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $3,740 on October 26, 2025, by the Defense Logistics Agency's Medical Supply Chain division. The contract, designated as XPCOV2/FLU/RSV-10, is structured as a firm fixed-price delivery order with an ultimate completion date of November 7, 2025, and carries no set-aside designation. This delivery order represents a continuation of Cepheid's extensive federal...
- Cepheid Inc., a leading molecular diagnostics manufacturer headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $13,096.80 by the Defense Logistics Agency Medical Supply Chain on October 28, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is for respiratory diagnostic testing supplies and is scheduled for completion by November 12, 2025. This award represents part of Cepheid's extensive federal supplier relationship, through which the company...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $20,400 firm fixed-price delivery order (Contract No. 4569897059) by the Defense Logistics Agency Medical Supply Chain on October 31, 2025, with an ultimate completion date of November 7, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, involves the supply of molecular diagnostic reagents and test kits for detecting COVID-19, influenza, and respiratory syncytial virus (RSV)—pathogens critical to military healthcare...
- The U.S. Defense Logistics Agency, through the Medical Supply Chain division, awarded a $4,080 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This delivery order, issued on June 18, 2025, with an ultimate completion date of June 26, 2025, is designated as XPCOV2/FLU/RSV-10 and carries no set-aside designation. The delivery order addresses federal requirements for COVID-19, influenza, and respiratory syncytial virus...
- The Defense Logistics Agency Medical Supply Chain awarded Cepheid Inc. a $14,037.50 firm fixed-price delivery order on November 3, 2025, for the Kit Xpert Xpress COVID-19, Flu, RSV + Molecular Biology diagnostic testing supplies. The contract, which is not subject to any set-aside designation, has an ultimate completion date of November 10, 2025, and will be performed at Cepheid's headquarters in Sunnyvale, California. This delivery order represents a continuation of DLA Medical Supply Chain's...
- The Defense Logistics Agency Medical Supply Chain awarded a $10,550 firm fixed-price delivery order to Cepheid Inc. on November 3, 2025, for the Kit Xpert Xpress COVID-19, Influenza, and Respiratory Syncytial Virus (RSV) plus Molecular Biology diagnostic testing supplies. The delivery order, which will be completed by November 10, 2025, represents a continuation of Cepheid's role as a primary federal supplier of molecular diagnostic solutions. This contract is not subject to any small business...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F6143Delivery Order
The Defense Logistics Agency Medical Supply Chain awarded Cepheid Inc. a firm fixed-price delivery order valued at $8,160 on October 28, 2025, for diagnostic reagents and test kits related to COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The delivery order, designated XPCOV2/FLU/RSV-10, carries an ultimate completion date of November 4, 2025, and will be performed at Cepheid's headquarters in Sunnyvale, California. This award utilizes no set-aside designation, reflecting the company's competitive positioning as a primary federal supplier of molecular diagnostic solutions. The contract represents a continuation of Cepheid's established role as a critical vendor for the Defense Logistics Agency's medical supply chain, providing essential diagnostic testing capabilities across federal healthcare systems. This delivery order falls within the broader context of Cepheid's extensive federal contracting portfolio, which includes substantial indefinite delivery contracts with the Department of Veterans Affairs valued at tens of millions of dollars through 2029–2030. As a leading manufacturer of the GeneXpert diagnostic platform and associated molecular testing systems, Cepheid has demonstrated significant capability in supplying rapid diagnostic testing solutions for infectious diseases to multiple federal agencies, including the Defense Health Agency, Indian Health Service, and U.S. Coast Guard. The modest ceiling value of this particular order reflects routine procurement replenishment rather than a major expansion of services, consistent with the company's pattern of providing firm fixed-price delivery orders across the federal healthcare procurement landscape.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.2k | 10/28/25 |